Mirum Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing treatments for rare diseases, particularly those affecting children. The company has three approved medications: LIVMARLI® (maralixibat) for cholestatic pruritus in Alagille syndrome and progressive familial intrahepatic cholestasis (PFIC), CHOLBAM® (cholic acid) for bile acid synthesis disorders, and CTEXLI™ (chenodiol) for cerebrotendinous xanthomatosis. Mirum is also advancing a pipeline of investigational treatments, including Volixibat for primary sclerosing cholangitis and Fragile X syndrome, showcasing its commitment to innovative solutions in rare disease therapy.
Mirum Pharmaceuticals is seeking a Senior Manager of Clinical Pharmacology to oversee the development and approval of their rare disease assets. This role will be a key member of the Clinical Pharmacology & Nonclinical Sciences group, focusing on defining strategy and executing studies/analyses through CROs to achieve team goals. The company values a collaborative, creative, and experienced environment.
Mirum Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing treatments for rare diseases, particularly those affecting children. The company has three approved medications: LIVMARLI® (maralixibat) for cholestatic pruritus in Alagille syndrome and progressive familial intrahepatic cholestasis (PFIC), CHOLBAM® (cholic acid) for bile acid synthesis disorders, and CTEXLI™ (chenodiol) for cerebrotendinous xanthomatosis. Mirum is also advancing a pipeline of investigational treatments, including Volixibat for primary sclerosing cholangitis and Fragile X syndrome, showcasing its commitment to innovative solutions in rare disease therapy.
Praxis Precision Medicines, Inc.